P

Inventor

MESAROS EUGEN F

US12 patents
⚠️ This page may combine multiple inventors who share the name “MESAROS EUGEN F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VENATORX PHARMACEUTICALS INC

4 patents
US10464952B2Nov 5, 2019

Beta-lactamase inhibitors

VENATORX PHARMACEUTICALS INC5 citations72
US11267826B2Mar 8, 2022

Penicillin-binding protein inhibitors

VENATORX PHARMACEUTICALS INC2 citations62
US12173018B2Dec 24, 2024

Penicillin-binding protein inhibitors

VENATORX PHARMACEUTICALS INC0 citations50
US11332485B2May 17, 2022

Penicillin-binding protein inhibitors

VENATORX PHARMACEUTICALS INC0 citations50

IGNYTA INC

2 patents
US9914730B2Mar 13, 2018

Azaquinazoline inhibitors of Atypical protein Kinase C

IGNYTA INC6 citations81
US9896446B2Feb 20, 2018

Azaquinazoline inhibitors of atypical protein kinase C

IGNYTA INC4 citations70

CEPHALON INC

2 patents
US8633173B2Jan 21, 2014

Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives

CEPHALON INC0 citations50
US9440984B2Sep 13, 2016

Pyrrolotriazines as ALK inhibitors

CEPHALON INC0 citations49

AHMED GULZAR

1 patent
US8552186B2Oct 8, 2013

Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors

AHMED GULZAR10 citations82

BRESLIN HENRY J

1 patent
US8471005B2Jun 25, 2013

Pyrrolotriazines as ALK and JAK2 inhibitors

BRESLIN HENRY J3 citations54

CURRY MATTHEW A

1 patent
US8501936B2Aug 6, 2013

Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives

CURRY MATTHEW A0 citations43

CANCER RESEARCH TECH LTD

1 patent
US10414763B2Sep 17, 2019

Azaquinazoline inhibitors of atypical protein kinase C

CANCER RESEARCH TECH LTD0 citations38